In PLOS this week: interaction of uracil-N-glycosylase and activation induced deaminase enzymes in B cell lymphoma, E. coli strains linked to bloodstream infections, and more.
The chief executive of BioNTech says the vaccine his company developed with Pfizer should be effective against the new SARS-CoV-2 strain found in the UK, the Guardian reports.
In PLOS this week: cancer predisposition syndromes among pediatric cancer patients, analysis of Plasmodium vivax population genomics in Panama, and more.
Xavier Becerra, the Health and Human Services Secretary nominee says his main focus, if confirmed, would be the pandemic, the Wall Street Journal reports.
Science reports that individuals with Down syndrome are at increased risk of dying from COVID-19, leading to calls for individuals with Down syndrome to be prioritized for vaccination.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.